FDA Approves MSD Animal Health’s MOMETAMAX SINGLE™ to Treat Otitis Externa in Dogs
The leading manufacturer of otic treatments expands portfolio with the only FDA-approved, one dose, in-clinic treatment for Pseudomonas aeruginosa and other pathogens RAHWAY, N.J., May 02, 2025 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the U.S. Food and Drug Administration (FDA) approval of MOMETAMAX SINGLE™ […]